Fibrolamellar Cancer Foundation

Research News

Memorial Sloan Kettering has just added specific reference to fibrolamellar liver cancer on their website:  http://www.mskcc.org/cancer-care/adult/liver/fibrolamellar-hepatocellular-carcinoma-fll-hcc

This website reference also includes the following research news information:

The Fibrolamellar Hepatocellular Carcinoma Consortium
The Fibrolamellar Hepatocellular Carcinoma Consortium is a collaborative initiative that has been developed to improve treatment options for people with FLL-HCC. Led by Memorial Sloan-Kettering Cancer Center in conjunction with Johns Hopkins University and the University of California, San Francisco, the consortium’s mission is to:
    promote awareness about FLL-HCC within the oncology community
    develop new therapies for FLL-HCC
    pool information on patients with FLL-HCC in order to document trends in diagnosis, treatment, and survival
The consortium will soon be opening a clinical trial testing a novel treatment designed specifically for FLL-HCC. The treatment will target certain cell-signaling pathways that appear to be overactive in this disease. This will be the first clinical trial dedicated to patients with advanced FLL-HCC that cannot be treated with surgery.

In addition, the consortium plans to open a registry to collect information on patients with FLL-HCC. Patients who agree to participate will be asked to donate a blood sample as well as available tumor material. These samples will be banked and used for future research projects on FLL-HCC.

*************************

The following article acknowledged FCF’s funding of Doctor Torbenson who was the recipient of one of four $50,000 "Freedom of Pursuit" research grants.

Fibrolamellar Carcinomas are Positive for CD68
Modern Pathology (2010)

Fibrolamellar carcinomas are a unique type of liver carcinoma that arise in non-cirrhotic livers of young individuals. Despite their distinctive appearance, recent studies have demonstrated a lack of consistency in how fibrolamellar carcinomas are diagnosed by pathologists. Read more >>

 

Announcements

Welcome

Welcome to our new website. We hope you find it interesting and informative. This is our modest beginning to develop this site into all things fibrolamellar, a place for patients, doctors, researchers and donors to help fight this killer cancer.
 

 

FCF Ambassadors

...are doing interesting and innovative things to raise money for the Foundation.  Check it out.

CT Nonprofit Web Design